# TING THERAPEUTICS, INC.: Therapeutics to prevent aminoglycoside-induced hearing loss

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | TING THERAPEUTICS, INC. |
| Location | San Diego, CA |
| Project | Therapeutics to prevent aminoglycoside-induced hearing loss |
| Project number | 5R44DC019065-05 |
| Mechanism | R44 |
| Institute | National Institute on Deafness and Other Communication Disorders |
| Award | $524,299 |
| Awarded | 2026-09-17 |
| Project period | 2020-07-17 to 2027-07-31 |
| UEI | F5R2ZH3HCHB5 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11380822). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.